NDC 70771-1833-01 - Sucralfate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70771-1833
Requested NDC
70771-1833-01
Package NDCs from labels
70771-1833-5, 70771-1833-3, 70771-1833-1, 70771-1833-01
Manufacturer
Zydus Lifesciences Limited
Effective date
2026-08-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Sucralfate - Zydus Lifesciences LimitedZydus Lifesciences Limited2026-08-08HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70771-1833-1Sucralfate100 in 1 BOTTLETABLET1002
70771-1833-3Sucralfate30 in 1 BOTTLETABLET302
70771-1833-5Sucralfate500 in 1 BOTTLETABLET5002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70771-1833SUCRALFATE TABLET [ZYDUS LIFESCIENCES LIMITED]2Current NDC, 3 package rows20240310_882b7596-f62c-4be2-8f67-e64310718baa.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 76 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SucralfateSUCRALFATEPreferred Pharmaceuticals Inc.536b8c00-13ab-4397-a754-63a1c92bf8832026-09-02Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATEVistaPharm, LLCcbfbe146-5d42-4a55-9050-df2b5581487a2026-09-02Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEPreferred Pharmaceuticals Inc.5ec71444-cc55-47bd-8abc-b3cfc3b47d8e2026-09-01Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATEChartwell RX, LLC37aee721-b9c7-4e6b-a1a1-e826d8541d6b2026-08-27Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEZydus Lifesciences Limited882b7596-f62c-4be2-8f67-e64310718baa2026-08-08Adverse reactionsExact identifier
application number: ANDA215705
ndc (package): 70771-1833-5
ndc (package): 70771-1833-1
ndc (package): 70771-1833-3
ndc (product): 70771-1833
ndc11 (package): 70771183301
rxcui: 314234
spl id: 3f731a84-c141-4e26-ade3-39a9e4ea30e3
spl set id: 882b7596-f62c-4be2-8f67-e64310718baa
unii: XX73205DH5
SucralfateSUCRALFATEViona Pharmaceuticals Incc708201b-2618-4470-a3ff-8ecf04d6b3a02026-08-08Adverse reactionsExact identifier
application number: ANDA215705
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATECardinal Health 107, LLC444a743a-4843-4b33-bad5-3dfc1fb2d0042026-07-29Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATESafecor Health, LLC526f6ebc-557c-4c53-8118-1907baa0820a2026-07-16Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATECardinal Health 107, LLC1eb38f64-4d5a-46e6-a030-057beece5e442026-07-10Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATEChartwell RX, LLC30c0965a-02a0-46b5-aa09-3f5fb5047b222026-07-06Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATENCS HealthCare of KY, LLC dba Vangard Labs3b0259fa-806f-44c1-8deb-c11dbd84582d2026-06-24Adverse reactionsExact identifier
application number: ANDA215705
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATEASCLEMED USA INC.cd25eb96-29ea-48b2-bdee-c2ea98f216b82026-05-18Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
Caldesene BabySTARCH, CORN AND ZINC OXIDEInsight Pharmaceuticals LLC9f12dee2-7afa-45e9-a729-0fd42bb777152026-04-22WarningsExact identifier
unii: O8232NY3SJ
Caldesene Medicated ProtectingCORNSTARCH AND ZINC OXIDEInsight Pharmaceuticals LLCffc92a0f-a7cf-4a46-b2f1-089df2bbb96b2026-04-22WarningsExact identifier
unii: O8232NY3SJ
SucralfateSUCRALFATESafecor Health LLC1a6d96f2-fe1f-4aaf-8520-616973c224aa2026-04-07Adverse reactionsExact identifier
rxcui: 314234
unii: XX73205DH5
SucralfateSUCRALFATECardinal Health 107, LLC92c8672a-c6b8-4ec8-a815-c30bdd960ac72026-03-30Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEPAI Holdings, LLC dba PAI Pharma113a068a-2ce9-421c-8b89-87ce30e192252026-03-11Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
sucralfateSUCRALFATEStrides Pharma Science Limited8e25bff2-769e-4bd4-a6de-895c58b840d22026-03-10Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATE ORAL SUSPENSIONMajor Pharmaceuticals98a8fedd-fa06-416a-8a85-b899631978f92026-02-11Warnings, Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEPreferred Pharmaceuticals Inca434bf8f-cc60-4d84-a9a4-61c3ff6b700e2026-01-21Adverse reactionsExact identifier
application number: ANDA215705
rxcui: 314234
unii: XX73205DH5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.